abstract |
The present invention relates to novel morpholinyl anthracycline derivatives having cytotoxic activity and useful in the treatment of diseases such as cancer, cell proliferative diseases and viral infections. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising them and methods of treating diseases using such compounds or pharmaceutical compositions comprising them. |